Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELIFE: Duloxetine for Opioid Sparing in Total Knee Arthroplasty
NCT06423716Phase 4Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Nov 2024
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine in knee osteoarthritis (OA), sponsored by Sunnybrook Health Sciences Centre. Started Nov 2024; status: recruiting.
02
Drugs
duloxetine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06423716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06423716.